US3776221A - Detecting impaired heart mechanical performance and apparatus therefor - Google Patents

Detecting impaired heart mechanical performance and apparatus therefor Download PDF

Info

Publication number
US3776221A
US3776221A US00130572A US3776221DA US3776221A US 3776221 A US3776221 A US 3776221A US 00130572 A US00130572 A US 00130572A US 3776221D A US3776221D A US 3776221DA US 3776221 A US3776221 A US 3776221A
Authority
US
United States
Prior art keywords
manoeuvre
pressure
blood pressure
impairment
heart
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US00130572A
Inventor
Intyre K Mc
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of US3776221A publication Critical patent/US3776221A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/02Detecting, measuring or recording pulse, heart rate, blood pressure or blood flow; Combined pulse/heart-rate/blood pressure determination; Evaluating a cardiovascular condition not otherwise provided for, e.g. using combinations of techniques provided for in this group with electrocardiography or electroauscultation; Heart catheters for measuring blood pressure
    • A61B5/021Measuring pressure in heart or blood vessels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/72Signal processing specially adapted for physiological signals or for diagnostic purposes
    • A61B5/7235Details of waveform analysis
    • A61B5/7239Details of waveform analysis using differentiation including higher order derivatives

Definitions

  • ABSTRACT A [52] us. Cl v. l28/2.05 R A pressure-sensitive device n cts the skin of a pa- [51] Int. Cl A61b 5/02 tient near an artery neninvasivelly to provide a signal 58 Field of Search 128/205 A, 2.05 E, representative of Systemic arterial blood pressure both l28/2.()5 F, 2,05 G, 205 M, 2 ()5 N, 2 05 p before and after a Valsalva Manoeuvre.
  • the present invention relates in general to detecting impaired mechanical performance of the heart and/or cardiac failure, and more particularly concerns novel apparatus and techniques for detecting such potential impairment in a reliable manner through external measurements.
  • aortic valve disease Since the introduction of aortic valvotomy, the assessment of aortic valve disease has become increasingly important. On approach to such an assessment involves studying recorded arterial pressure pulse tracings. Stenosis is the narrowing of a blood passage, such as the pulmonary artery or aortic valve. One approach to studying stenosis is the so-called Valsalva Manoeuvre. The patients blood pressure is recorded prior to holding his breath. Then the patient holds his breath and releases it while recording continues.
  • the time derivative of the systemic arterial pulse pressure is'established at a control level in the subject patient. Then the patient performs a straining manoeuvre, such as Valsalva manoeuvre, while recording the time derivative of the systemic arterial pulse pressure signal.
  • the systemic arterial pulse pressure, mean pressure, heart rate and left ventricular ejection time are also established and may be interpreted so that the presence or absence of impairment in the performance of the left ventricle may be detected.
  • the time derivative of systemic arterial pressure responds in a characteristic fashion in the presence of heart impairment; the other parameters are useful in defining the expected normal response of the time derivative of this pressure.
  • FIG. 1 is a graphical representation of stroke volume as a function of end-diastolic pressure on the left ventricle during a Valsalva maoeuvre helpful in understanding the phenomenon with which the invention is assocated;
  • FIG. 2 is a block diagram illustrating the logical arrangement of a system according to the invention which includes means for detecting left ventricle mechanical impairment;
  • FIG. 3 is a graphical representation of time derivative of pressure waveforms helpful in understanding the operation of the invention.
  • FIG. 1 a graphical representation of stroke volume as a function of enddiastolic pressure at the left ventricle during a Valsalva manoeuvre.
  • Curve 11 illustrates this relationshio for a normal left ventricle.
  • Point 1 represents the normal stroke volume and end-diastolic pressure immediately prior to the patient holding his breath.
  • both pressure and stroke volume decrease along curve 11 to point 2 when the patient releases his breath.
  • Stroke volume and enddiastolic pressure then begin to increase rapidly until point 3 is reached.
  • This analysis indicates that the time derivative of the pressure signal of a healthy patient will increase significantly when he releases his breath. Since other changes occur during the Valsalva manoeuvre which may on occasion independently influence the response of stroke volume and the time derivative of pressure, the influence of such changes as heart rate and left ventricular ejection time are also measured.
  • Curve 12 is the curve illustrating the relationship between stroke volume and end-diastolic pressure of the left ventricle of a person having left ventricle mechanical impairment. Point 1' is just before the patient holds his breath. He then makes a forceful expiratory effort without allowing air to escape. This initial pressure (EDP) is somewhat higher and the initial stroke volume (SV) usually somewhat lower than for a normal person,
  • the invention senses a recovery derivative signal to indicate left ventricular impairment when this amplitude is equal to or less than a predetermined value.
  • the invention may include a number of different sources of a pressure signal.
  • One such source may be apiezoelectric pulse pick up 11, an impedance plethysmograph 12 or a sphygmamanometer 13 whose pressure signal is converted by transducer 14 into an electrical signal that is delivered to amplifier means 15.
  • Each of these sources is pressure sensitive means noninvasive of the human body and derives a signal from contact with the skin surface near an artery.
  • Amplifier means includes means for amplifying one of the selected pressure signals and providing the amplified pressure signal to differentiator 16 that provides a differentiated pressure signal for analysis.
  • the apparatus also may include computer analysis control recovery means 21, which may receive a pressure signal from amplifier means 15 and a computer analysis control recovery means 22 for responding to the time derivative pressure signal provided by differentiator 1 6.
  • Computer analysis control recovery means 21 preferably responds to heart rate, systemic arterial pulse pressure, peak systemic pressure, systemic mean pressure and left ventricular ejection time so that changes in these latter parameters may be used to more accurately define the predicted normal range for the time derivative of systemic arterial pulse and to provide a 1 signal to indicate a condition consistent with left ventricular mechanical impairment and a 2 signal to indicate a signal inconsistent with left ventricular mechanical impairment.
  • computer analysis control recovery means 22 provides a 1 signal consistent with left ventricular failure and a 2 signal consistent with no failure. These 1 signals are applied to an AND gate 23 which provides an output to indicate left ventricular of a second AND gate 24 that provides an output to indicate no ventricular failure.
  • the invention may also comprise write-out means 25, which may be a graphical recorder whose output may be manually analyzed or appear on calibrated paper that automatically displays the presence or absence of mechanical impairment.
  • write-out means 25 may be a graphical recorder whose output may be manually analyzed or appear on calibrated paper that automatically displays the presence or absence of mechanical impairment.
  • FIG. 3 there is shown three pairs of pulses that might be recorded during the course of a Valsalva manoeuvre.
  • the first pair of pulses 31 occurs prior to holding the breath.
  • the gain of amplifier means 15 is then adjusted so that the peak of the time derivative pressure waveform just reached the control line 32 with baseline adjusted 31A.
  • the breath is released, if the pulses have a height, such as that of pair 33, that is less than level 34, left ventricular mechanical impairment is probable. If they have a height greater than level 34, such as that of pulse pair 35, there is no left ventricular impairment.
  • the heart rate signals, systemic pulse pressure signals, peak systemic pressure signals, mean systemic pressure signals and left ventricular ejection time signals are subjected to further computer analysis to determine the extent to which certain of these parameters may independently alter the time derivative signal. For example, if changes in heart rate, the systemic arterial pulse pressure, mean pressure, systolic peak pressure and left ventricular ejection time are greater than a predetermined level, a second independent reanalysis of the pressure derivative signal is provided which takes into account the possible influence of changes in the latter parameters on the time derivative of pressure. Such an analysis is unlikely to be required in routine use but will improve the accuracy of the instrument.
  • heart rate is readily determined by a digital counter whose count is compared by known techniques with a predetermined reference count equal to a control heart rate.
  • the other two pressures may be readily determined by analog comparison techniques or by first converting these signals to digital values and making the comparison digitally.
  • the derivative signal itself provided by differentiator 16 is most significant. Those skilled in the art might also determine the derivative by analyzing the pressure signal.
  • An advantage of differentiating before analyzing is that shifts in d-c pressure levels are essentially removed so that the resultant output signal waveform clearly represents a manifestation of the change in rate of pressure as a function of time to facilitate diagnosing left ventricular impairment.
  • a method of detecting mechanical heart impairment which method includes the steps of,
  • a method of detecting mechanical heart impairment in accordance with claim 1 and further including the steps of providing signals representative of systemic peak pressure, systemic mean pressure, heart rate, and left ventrical ejection time both before and after said manoeuvre and sensing the differences between respective signals before and after said manoeuvre.
  • a method of detecting mechanical heart impairment in accordance with claim 1 which method includes the steps of,
  • pressure sensitive means responsive to said blood pressure for providing said blood pressure signal

Abstract

A pressure-sensitive device contacts the skin of a patient near an artery noninvasively to provide a signal representative of systemic arterial blood pressure both before and after a Valsalva Manoeuvre. This blood pressure signal is differentiated, and the changes in amplitude before and after the Valsalva Manoeuvre detected to indicate potential left ventricle failure when the change is less than a predetermined value. Signals representative of pulse pressure, the mean systemic arterial blood pressure, heart rate and left ventricular ejection time are also provided to facilitate detection of impaired mechanical performance of the heart.

Description

United States Patent 1 1111 3,776,221
McIntyre Dec. 4, 1973 DETECTING IMPAIRED HEART MECHANICAL PERFORMANCE AND APPARATUS THEREFOR OTHER PUBLICATIONS George et al., Medical Research Engineering, 4th quarter, 1967, pp. 21-24.
[76] Inventor: Kevin M. McIntyre, 1400 V.F.W.
Pky., Jamaica Plam, Mass. 021,36 Primary Examiner wimam E Kamm [22] Filed: Apr. 2, IP71 Attorney-Charles Hieken [21] Appl. No.: 130,572
[57] ABSTRACT A [52] us. Cl v. l28/2.05 R A pressure-sensitive device n cts the skin of a pa- [51] Int. Cl A61b 5/02 tient near an artery neninvasivelly to provide a signal 58 Field of Search 128/205 A, 2.05 E, representative of Systemic arterial blood pressure both l28/2.()5 F, 2,05 G, 205 M, 2 ()5 N, 2 05 p before and after a Valsalva Manoeuvre. This blood 2 ()5 Q, 2 ()5 R 2 05 T 2 ()5 V pressure signal is differentiated, and the changes in amplitude before and after the Valsalva Manoeuvre [56] References Cit d detected to indicate potential left ventricle failure UNITED STATES PATENTS when the change is less than a predetermined value. 2,667,159 1/1954 Goldberg etal. 128/205 v represlematwe pulse pressure the means 3 154 066 10/1964 Grindheim et al 128/2 05 P systemic arterial blood pressure, heart rate and left 3400709 9/1968 Punt-stuck 128 A ventricular ejection time are also provided to facilitate 3:412:729 11/1968 Smith, Jr 128 205 R detection of impaired mechanical Performance of the heart. FOREIGN PATENTS OR APPLICATIONS 1,053,723 3/1959 Germany [ZS/2.05 Q 7 Claims, 3 Drawing Figures COMPUTER ANALYSIS CONTROL RECOVERY MEANs HEART RATE g 0R LV EJECTI TIME N PIEZO- 0R ELECTRIC PULSE PRESS. o
E MEAN PRESS I PEAK PRESS. 2(@
I I5 25 I4\ f I 24 I3 SPHYGMO TRANS- i 'igffggg WRITE-OUT 136??? MANOMETER DUCER MEANs MEANs '''t AND L VF -o |2 IMPEDANCE PLETHYSMO A 22 3 GRAPH 6 COMPUTER ANALYSIS DER'VAT'VE CONTROL RECOVERY MAX dp/dt ME'ANS DIFFERENTIATOR N =OR DETECTING IMPAIRED HEART MECHANICAL PERFORMANCE AND APPARATUS THEREFOR BACKGROUND OF THE INVENTION The present invention relates in general to detecting impaired mechanical performance of the heart and/or cardiac failure, and more particularly concerns novel apparatus and techniques for detecting such potential impairment in a reliable manner through external measurements.
Since the introduction of aortic valvotomy, the assessment of aortic valve disease has become increasingly important. On approach to such an assessment involves studying recorded arterial pressure pulse tracings. Stenosis is the narrowing of a blood passage, such as the pulmonary artery or aortic valve. One approach to studying stenosis is the so-called Valsalva Manoeuvre. The patients blood pressure is recorded prior to holding his breath. Then the patient holds his breath and releases it while recording continues.
Reference is 'made to an article entitled THE VAL- SALVA MANOEUVRE IN AORTIC VALVE DIS- EASE by Doyle and Neilson. The article states that neither systolic upstroke time nor pulse pressure alone correlates well with the severity of stenosis and that the shape of the pulse derived during Valsalva Manoeuvre is an unreliable guide to the relative dominance of stenosis or incompetence. That article concludes that variations in pulse pressure during the Valsalva Manoeuvre or in atrial fibrillation and variations of upstroke time in the same pulses do not have a linear relationship to the severity of stenosis when stenosis is present alone.
It is an important object of this invention to provide improved techniques for detecting left ventricular impairment.
It is a further object of the invention to achieve the preceding object with techniques and apparatus that permit detection by relatively unskilled personnel.
SUMMARY OF THE INVENTION According to the invention, the time derivative of the systemic arterial pulse pressure is'established at a control level in the subject patient. Then the patient performs a straining manoeuvre, such as Valsalva manoeuvre, while recording the time derivative of the systemic arterial pulse pressure signal. Preferably, the systemic arterial pulse pressure, mean pressure, heart rate and left ventricular ejection time are also established and may be interpreted so that the presence or absence of impairment in the performance of the left ventricle may be detected. Specifically, the time derivative of systemic arterial pressure responds in a characteristic fashion in the presence of heart impairment; the other parameters are useful in defining the expected normal response of the time derivative of this pressure.
Numerous other features, objects and advantages of the invention will become apparent from the following specification when read in connection with the accompanying drawing in which:
BRIEF DESCRIPTION OF THE DRAWING FIG. 1 is a graphical representation of stroke volume as a function of end-diastolic pressure on the left ventricle during a Valsalva maoeuvre helpful in understanding the phenomenon with which the invention is assocated;
FIG. 2 is a block diagram illustrating the logical arrangement of a system according to the invention which includes means for detecting left ventricle mechanical impairment; and
FIG. 3 is a graphical representation of time derivative of pressure waveforms helpful in understanding the operation of the invention.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS With reference now to the drawing, and more particularly FIG. 1 thereof, there is shown a graphical representation of stroke volume as a function of enddiastolic pressure at the left ventricle during a Valsalva manoeuvre. Curve 11 illustrates this relationshio for a normal left ventricle. Point 1 represents the normal stroke volume and end-diastolic pressure immediately prior to the patient holding his breath. As the patient holds his breath and makes a forceful expiratory effort without allowing air to escape from his lungs (equivalent to straining at stool), both pressure and stroke volume decrease along curve 11 to point 2 when the patient releases his breath. Stroke volume and enddiastolic pressure then begin to increase rapidly until point 3 is reached. This analysis indicates that the time derivative of the pressure signal of a healthy patient will increase significantly when he releases his breath. Since other changes occur during the Valsalva manoeuvre which may on occasion independently influence the response of stroke volume and the time derivative of pressure, the influence of such changes as heart rate and left ventricular ejection time are also measured.
Curve 12 is the curve illustrating the relationship between stroke volume and end-diastolic pressure of the left ventricle of a person having left ventricle mechanical impairment. Point 1' is just before the patient holds his breath. He then makes a forceful expiratory effort without allowing air to escape. This initial pressure (EDP) is somewhat higher and the initial stroke volume (SV) usually somewhat lower than for a normal person,
then decreases to point 2' shortly before the breath is released. When breath is released, the blood which was prevented from returning to the heart does so at an increased rate, causing an increase in end-diastolic pressure. During the positive pressure phase, pressure generated in the chest exceeds the pressure of returning blood.
In a patient with mechanical impairment of the heart, no increase in stroke volume occurs with a rise in enddiastolic pressure (position 3), and this is detectable by a failure of the time derivative of the systemic arterial pulse pressure to increase. The range of changes which occur are acceptable in the individual patient depending to some extent on changes in other parameters, such as heart rate and left ventricular ejection time.
Referring to FIG. 2, there is shown a block diagram illustrating the logical arrangement of a system according to the invention. Basically the invention senses a recovery derivative signal to indicate left ventricular impairment when this amplitude is equal to or less than a predetermined value. To this end the invention may include a number of different sources of a pressure signal. One such source may be apiezoelectric pulse pick up 11, an impedance plethysmograph 12 or a sphygmamanometer 13 whose pressure signal is converted by transducer 14 into an electrical signal that is delivered to amplifier means 15. Each of these sources is pressure sensitive means noninvasive of the human body and derives a signal from contact with the skin surface near an artery. Amplifier means includes means for amplifying one of the selected pressure signals and providing the amplified pressure signal to differentiator 16 that provides a differentiated pressure signal for analysis.
The apparatus also may include computer analysis control recovery means 21, which may receive a pressure signal from amplifier means 15 and a computer analysis control recovery means 22 for responding to the time derivative pressure signal provided by differentiator 1 6. Computer analysis control recovery means 21 preferably responds to heart rate, systemic arterial pulse pressure, peak systemic pressure, systemic mean pressure and left ventricular ejection time so that changes in these latter parameters may be used to more accurately define the predicted normal range for the time derivative of systemic arterial pulse and to provide a 1 signal to indicate a condition consistent with left ventricular mechanical impairment and a 2 signal to indicate a signal inconsistent with left ventricular mechanical impairment. Similarly computer analysis control recovery means 22 provides a 1 signal consistent with left ventricular failure and a 2 signal consistent with no failure. These 1 signals are applied to an AND gate 23 which provides an output to indicate left ventricular of a second AND gate 24 that provides an output to indicate no ventricular failure.
The invention may also comprise write-out means 25, which may be a graphical recorder whose output may be manually analyzed or appear on calibrated paper that automatically displays the presence or absence of mechanical impairment.
Referring to FIG. 3, there is shown three pairs of pulses that might be recorded during the course of a Valsalva manoeuvre. The first pair of pulses 31 occurs prior to holding the breath. The gain of amplifier means 15 is then adjusted so that the peak of the time derivative pressure waveform just reached the control line 32 with baseline adjusted 31A. After the breath is released, if the pulses have a height, such as that of pair 33, that is less than level 34, left ventricular mechanical impairment is probable. If they have a height greater than level 34, such as that of pulse pair 35, there is no left ventricular impairment.
If the height is less than level 34, such as that of pulse pair 33, then the heart rate signals, systemic pulse pressure signals, peak systemic pressure signals, mean systemic pressure signals and left ventricular ejection time signals are subjected to further computer analysis to determine the extent to which certain of these parameters may independently alter the time derivative signal. For example, if changes in heart rate, the systemic arterial pulse pressure, mean pressure, systolic peak pressure and left ventricular ejection time are greater than a predetermined level, a second independent reanalysis of the pressure derivative signal is provided which takes into account the possible influence of changes in the latter parameters on the time derivative of pressure. Such an analysis is unlikely to be required in routine use but will improve the accuracy of the instrument.
Details of the various elements of the system represented by the boxes have not been described to avoid obscuring the principles of this invention and because such elements are known to those having ordinary skill in the signal analysis art.
For example, heart rate is readily determined by a digital counter whose count is compared by known techniques with a predetermined reference count equal to a control heart rate. The other two pressures may be readily determined by analog comparison techniques or by first converting these signals to digital values and making the comparison digitally.
While the preferred embodiment of the invention contemplates utilizing both derivatives and other signals in sensing for mechanical impairment of the heart, the derivative signal itself provided by differentiator 16 is most significant. Those skilled in the art might also determine the derivative by analyzing the pressure signal.
An advantage of differentiating before analyzing is that shifts in d-c pressure levels are essentially removed so that the resultant output signal waveform clearly represents a manifestation of the change in rate of pressure as a function of time to facilitate diagnosing left ventricular impairment.
There has been described novel apparatus and techniques for facilitating the detection of mechanical heart impairment by relatively unskilled personnel. It is evident that those skilled in the art may now make numerous uses and modifications of and departures from the specific embodiments disclosed herein without departing from the inventive concepts. Consequently, the invention is to be construed as embracing each and every novel feature and novel combination of features present in or possessed by the apparatus and techniques herein disclosed and limited solely by the spirit and scope of the appended claims.
What is claimed is:
l. A method of detecting mechanical heart impairment which method includes the steps of,
noninvasively providing a blood pressure signal representative of blood pressure by placing pressure sensitive means in contact with the skin of a patient near an artery,
differentiating said blood pressure signal,
subjecting said patient whose blood pressure is characterized by said pressure signal to a heart straining manoeuvre,
detecting the change in the amplitude of the differentiated pressure signal after said manoeuvre from its amplitude before said manoeuvre,
and determining a probable mechanical impairment of the heart when said change is less than a predetermined value.
2. A method of detecting mechanical heart impairment in accordance with claim 1 wherein said heart straining manoeuvre is a Valsalva manoeuvre and said signal representative of blood pressure is representative of systemic arterial blood pressure.
3. A method of detecting mechanical heart impairment in accordance with claim 2 wherein said Valsalva manoeuvre is involuntarily induced in said patient.
4. A method of detecting mechanical heart impairment in accordance with claim 1 and further including the steps of providing signals representative of systemic peak pressure, systemic mean pressure, heart rate, and left ventrical ejection time both before and after said manoeuvre and sensing the differences between respective signals before and after said manoeuvre.
5. A method of detecting mechanical heart impairment in accordance with claim 1 which method includes the steps of,
recording the differentiated blood pressure signal so that its peak amplitude before said manoeuvre is between a baseline and predetermined control line and observing the amplitude of said differentiated 6 means for detecting the change in the amplitude of the differentiated pressure signal after said manoeuvre from its amplitude before said manoeuvre including means for recording said differentiated blood pressure signal immediately after said ma 5 pressure signal before and after said manoeuvre to noeuvre relative to a predetermined normal limit provide an indication of the changes in the differline spaced from said control line to determine poentiated pressure signal before and after said matential mechanical impairment when the peak amnoeuvre,
plitude after said manoeuvre is between the control and means for determining a probable mechanical line and the acceptable level line, mechanical heart 10 impairment of the heart when said change is less impairment when then below said control line and no mechanical impairment when above said acthan a predetermined value. 7. Apparatus in accordance with claim 6 and further ceptable level line. 6. Apparatus for practicing the method of claim 1 comprising,
comprising means responsive to said blood pressure signal for deriving signals representative of heart rate, pulse pressure and peak pressure,
pressure sensitive means responsive to said blood pressure for providing said blood pressure signal,
means for differentiating said blood pressure signal to provide a differentiated pressure signal representative of the time derivative of said blood pressure,
and means responsive to said differentiated pressure signal, said heart rate, said pulse pressure and said peak pressure for providing an indication of mechanical heart impairment.

Claims (7)

1. A method of detecting mechanical heart impairment which method includes the steps of, noninvasively providing a blood pressure signal representative of blood pressure by placing pressure sensitive means in contact with the skin of a patient near an artery, differentiating said blood pressure signal, subjecting said patient whose blood pressure is characterized by said pressure signal to a heart straining manoeuvre, detecting the change in the amplitude of the differentiated pressure signal after said manoeuvre from its amplitude before said manoeuvre, and determining a probable mechanical impairment of the heart when said change is less than a predetermined value.
2. A method of detecting mechanical heart impairment in accordance with claim 1 wherein said heart straining manoeuvre is a Valsalva manoeuvre and said signal representative of blood pressure is representative of systemic arterial blood pressure.
3. A method of detecting mechanical heart impairment in accordance with claim 2 wherein said Valsalva manoeuvre is involuntarily induced in said patient.
4. A method of detecting mechanical heart impairment in accordance with claim 1 and further including the steps of providing signals representative of systemic peak pressure, systemic mean pressure, heart rate, and left ventrical ejection time both before and after said manoeuvre and sensing the differences between respective signals before and after said manoeuvre.
5. A method of detecting mechanical heart impairment in accordance with claim 1 which method includes the steps of, recording the differentiated blood pressure signal so that its peak amplitude before said manoeuvre is between a baseline and predetermined control line and observing the amplitude of said differentiated blood pressure signal immediately after said manoeuvre relative to a predetermined normal limit line spaced from said control line to determine potential mechanical impairment when the peak amplitude after said manoeuvre is between the control line and the acceptable level line, mechanical heart impairment when then below said control line and no mechanical impairment when above said acceptable level line.
6. Apparatus for practicing the method of claim 1 comprising, pressure sensitive means responsive to said blood pressure for providing said blood pressure signal, means for differentiating said blood pressure signal to provide a differentiated pressure signal representative of the time derivative of said blood pressure, means for detecting the change in the amplitude of the differentiated pressure signal after said manoeuvre from its amplitude before said manoeuvre including means for recording said differentiated pressure signal before and after said manoeuvre to provide an indication of the changes in the differentiated pressure signal before and after said manoeuvre, and meaNs for determining a probable mechanical impairment of the heart when said change is less than a predetermined value.
7. Apparatus in accordance with claim 6 and further comprising means responsive to said blood pressure signal for deriving signals representative of heart rate, pulse pressure and peak pressure, and means responsive to said differentiated pressure signal, said heart rate, said pulse pressure and said peak pressure for providing an indication of mechanical heart impairment.
US00130572A 1971-04-02 1971-04-02 Detecting impaired heart mechanical performance and apparatus therefor Expired - Lifetime US3776221A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13057271A 1971-04-02 1971-04-02

Publications (1)

Publication Number Publication Date
US3776221A true US3776221A (en) 1973-12-04

Family

ID=22445304

Family Applications (1)

Application Number Title Priority Date Filing Date
US00130572A Expired - Lifetime US3776221A (en) 1971-04-02 1971-04-02 Detecting impaired heart mechanical performance and apparatus therefor

Country Status (1)

Country Link
US (1) US3776221A (en)

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908639A (en) * 1971-04-02 1975-09-30 Kevin M Mcintyre Detecting impaired heart mechanical performance
US3980075A (en) * 1973-02-08 1976-09-14 Audronics, Inc. Photoelectric physiological measuring apparatus
US4030485A (en) * 1974-11-12 1977-06-21 Glenfield Warner Method and apparatus for continuously monitoring systolic blood pressure
US4094308A (en) * 1976-08-19 1978-06-13 Cormier Cardiac Systems, Inc. Method and system for rapid non-invasive determination of the systolic time intervals
US4289141A (en) * 1976-08-19 1981-09-15 Cormier Cardiac Systems, Inc. Method and apparatus for extracting systolic valvular events from heart sounds
US4290434A (en) * 1978-05-15 1981-09-22 Vita Vet Research Group Inc. Blood pressure measuring device
US4425920A (en) 1980-10-24 1984-01-17 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
US4428380A (en) 1980-09-11 1984-01-31 Hughes Aircraft Company Method and improved apparatus for analyzing activity
JPS61279229A (en) * 1985-06-03 1986-12-10 ケヴイン・エム・マツキンタイア− Method and apparatus for evaluating mechanical capacity of heart
US4628939A (en) * 1980-09-11 1986-12-16 Hughes Aircraft Company Method and improved apparatus for analyzing heart activity
US5086776A (en) * 1990-03-06 1992-02-11 Precision Diagnostics, Inc. Apparatus and method for sensing cardiac performance
EP0534022A1 (en) * 1991-09-26 1993-03-31 McIntyre, Kevin M. Evaluation of heart mechanical performance
US6610018B1 (en) 2002-02-14 2003-08-26 Mcintyre Kevin M. Non-invasive determination of left-ventricular pressure
WO2003098177A2 (en) * 2002-05-14 2003-11-27 Savacor, Inc. Minimally invasive calibration of implanted pressure transducers
US7020514B1 (en) * 1999-12-20 2006-03-28 Joseph Wiesel Method of and apparatus for detecting atrial fibrillation
US7329226B1 (en) 2004-07-06 2008-02-12 Cardiac Pacemakers, Inc. System and method for assessing pulmonary performance through transthoracic impedance monitoring
US20080034836A1 (en) * 2002-05-14 2008-02-14 Pacesetter, Inc. System for calibrating implanted sensors
US7488290B1 (en) 2004-02-19 2009-02-10 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through transcardiac impedance monitoring
US8025624B2 (en) 2004-02-19 2011-09-27 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through cardiac vibration monitoring
US20120108915A1 (en) * 2010-10-29 2012-05-03 Giorgio Corbucci Posture-induced changes to physiological parameters
US8781847B2 (en) 2005-05-03 2014-07-15 Cardiac Pacemakers, Inc. System and method for managing alert notifications in an automated patient management system
US10376694B2 (en) 2008-10-09 2019-08-13 Virender K. Sharma Method and apparatus for stimulating the vascular system
US10603489B2 (en) 2008-10-09 2020-03-31 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
US11540734B2 (en) 2018-08-27 2023-01-03 Verily Life Sciences Llc Apparatus for noninvasive measurement of a heart performance metric

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2667159A (en) * 1948-12-21 1954-01-26 Harold D Goldberg Plethysmograph
DE1053723B (en) * 1953-04-08 1959-03-26 Dr Med Karl Brecht Arrangement for generating the pressure in a blood pressure cuff or pad characterizing marking pulses for electrical devices that register the pulse shape
US3154066A (en) * 1961-10-11 1964-10-27 Robert L Gannon Body function sensors
US3400709A (en) * 1965-10-01 1968-09-10 Statham Instrument Inc Arterial blood pressure monitor
US3412729A (en) * 1965-08-30 1968-11-26 Nasa Usa Method and apparatus for continuously monitoring blood oxygenation, blood pressure, pulse rate and the pressure pulse curve utilizing an ear oximeter as transducer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2667159A (en) * 1948-12-21 1954-01-26 Harold D Goldberg Plethysmograph
DE1053723B (en) * 1953-04-08 1959-03-26 Dr Med Karl Brecht Arrangement for generating the pressure in a blood pressure cuff or pad characterizing marking pulses for electrical devices that register the pulse shape
US3154066A (en) * 1961-10-11 1964-10-27 Robert L Gannon Body function sensors
US3412729A (en) * 1965-08-30 1968-11-26 Nasa Usa Method and apparatus for continuously monitoring blood oxygenation, blood pressure, pulse rate and the pressure pulse curve utilizing an ear oximeter as transducer
US3400709A (en) * 1965-10-01 1968-09-10 Statham Instrument Inc Arterial blood pressure monitor

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
George et al., Medical Research Engineering, 4th quarter, 1967, pp. 21 24. *

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3908639A (en) * 1971-04-02 1975-09-30 Kevin M Mcintyre Detecting impaired heart mechanical performance
US3980075A (en) * 1973-02-08 1976-09-14 Audronics, Inc. Photoelectric physiological measuring apparatus
US4030485A (en) * 1974-11-12 1977-06-21 Glenfield Warner Method and apparatus for continuously monitoring systolic blood pressure
US4094308A (en) * 1976-08-19 1978-06-13 Cormier Cardiac Systems, Inc. Method and system for rapid non-invasive determination of the systolic time intervals
US4289141A (en) * 1976-08-19 1981-09-15 Cormier Cardiac Systems, Inc. Method and apparatus for extracting systolic valvular events from heart sounds
US4290434A (en) * 1978-05-15 1981-09-22 Vita Vet Research Group Inc. Blood pressure measuring device
US4628939A (en) * 1980-09-11 1986-12-16 Hughes Aircraft Company Method and improved apparatus for analyzing heart activity
US4428380A (en) 1980-09-11 1984-01-31 Hughes Aircraft Company Method and improved apparatus for analyzing activity
US4425920A (en) 1980-10-24 1984-01-17 Purdue Research Foundation Apparatus and method for measurement and control of blood pressure
EP0204394A1 (en) 1985-06-03 1986-12-10 McIntyre, Kevin M. Apparatus for evaluating heart mechanical performance
JPS61279229A (en) * 1985-06-03 1986-12-10 ケヴイン・エム・マツキンタイア− Method and apparatus for evaluating mechanical capacity of heart
JPH089U (en) * 1985-06-03 1996-01-19 ケヴィン・エム・マッキンタイアー Device for assessing the mechanical status of the heart
US5086776A (en) * 1990-03-06 1992-02-11 Precision Diagnostics, Inc. Apparatus and method for sensing cardiac performance
EP0534022A1 (en) * 1991-09-26 1993-03-31 McIntyre, Kevin M. Evaluation of heart mechanical performance
US7020514B1 (en) * 1999-12-20 2006-03-28 Joseph Wiesel Method of and apparatus for detecting atrial fibrillation
US6610018B1 (en) 2002-02-14 2003-08-26 Mcintyre Kevin M. Non-invasive determination of left-ventricular pressure
US7621879B2 (en) 2002-05-14 2009-11-24 Pacesetter, Inc. System for calibrating implanted sensors
US20040019285A1 (en) * 2002-05-14 2004-01-29 Neal Eigler Apparatus for minimally invasive calibration of implanted pressure transducers
WO2003098177A3 (en) * 2002-05-14 2004-06-24 Savacor Inc Minimally invasive calibration of implanted pressure transducers
US7195594B2 (en) 2002-05-14 2007-03-27 Pacesetter, Inc. Method for minimally invasive calibration of implanted pressure transducers
WO2003098177A2 (en) * 2002-05-14 2003-11-27 Savacor, Inc. Minimally invasive calibration of implanted pressure transducers
US20080034836A1 (en) * 2002-05-14 2008-02-14 Pacesetter, Inc. System for calibrating implanted sensors
US7862513B2 (en) 2002-05-14 2011-01-04 Pacesetter, Inc. Apparatus for minimally invasive calibration of implanted pressure transducers
US8888710B2 (en) 2004-02-19 2014-11-18 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through cardiac vibration monitoring
US7488290B1 (en) 2004-02-19 2009-02-10 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through transcardiac impedance monitoring
US8025624B2 (en) 2004-02-19 2011-09-27 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through cardiac vibration monitoring
US8795189B2 (en) 2004-07-06 2014-08-05 Cardiac Pacemakers, Inc. System and method for determining pulmonary performance from transthoracic impedance measures
US7329226B1 (en) 2004-07-06 2008-02-12 Cardiac Pacemakers, Inc. System and method for assessing pulmonary performance through transthoracic impedance monitoring
US8781847B2 (en) 2005-05-03 2014-07-15 Cardiac Pacemakers, Inc. System and method for managing alert notifications in an automated patient management system
US10376694B2 (en) 2008-10-09 2019-08-13 Virender K. Sharma Method and apparatus for stimulating the vascular system
US10603489B2 (en) 2008-10-09 2020-03-31 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
US11517749B2 (en) 2008-10-09 2022-12-06 Virender K. Sharma Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage
US20120108915A1 (en) * 2010-10-29 2012-05-03 Giorgio Corbucci Posture-induced changes to physiological parameters
US8428720B2 (en) * 2010-10-29 2013-04-23 Medtronic, Inc. Posture-induced changes to physiological parameters
US9020594B2 (en) 2010-10-29 2015-04-28 Medtronic, Inc. Posture-induced changes to physiological parameters
US11540734B2 (en) 2018-08-27 2023-01-03 Verily Life Sciences Llc Apparatus for noninvasive measurement of a heart performance metric

Similar Documents

Publication Publication Date Title
US3776221A (en) Detecting impaired heart mechanical performance and apparatus therefor
US3908639A (en) Detecting impaired heart mechanical performance
Smith et al. Application of impedance cardiography to study of postural stress
US4446872A (en) Method and apparatus for determining systolic time intervals
US7137955B2 (en) Methods and systems for distal recording of phonocardiographic signals
US5406952A (en) Blood pressure monitoring system
US5647369A (en) Apparatus and methods for the noninvasive measurment of cardiovascular system parameters
US4677984A (en) Calibrated arterial pressure measurement device
US5291895A (en) Evaluation of heart mechanical performance
Willems et al. On the value of apex cardiography for timing intracardiac events
US4203451A (en) Cardiovascular analysis, method and apparatus
US20060224070A1 (en) System and method for non-invasive cardiovascular assessment from supra-systolic signals obtained with a wideband external pulse transducer in a blood pressure cuff
US4649929A (en) Method and apparatus for diagnosis of coronary artery disease
US20090012411A1 (en) Method and apparatus for obtaining electronic oscillotory pressure signals from an inflatable blood pressure cuff
US5365933A (en) Apparatus and method for distinguishing heart beats from intra-aortic balloon pump beats
Kerola et al. Non-invasive blood pressure data acquisition employing pulse transit time detection
US5687731A (en) Oscillometric method for determining hemodynamic parameters of the arterial portion of patient's circulatory system and a measuring system for its realization
US3085567A (en) Frequency selective method and apparatus for sphygmomanometry
Buchbinder et al. Arterial blood pressure in cases of auricular fibrillation, measured directly
US3623476A (en) Blood pressure measurement apparatus
EP0204394B1 (en) Apparatus for evaluating heart mechanical performance
Koohi et al. Dynamic threshold algorithm to evaluate trustworthiness of the estimated blood pressure in oscillometry
EP0148819A1 (en) Method and apparatus for diagnosis of coronary artery disease
Manolas et al. Relationship between duration of systolic upstroke of apexcardiogram and internal indexes of myocardial function in man
Zoneraich et al. Computerized system for noninvasive techniques: I. Its value for systolic time intervals